Cargando…
Response of FcεRI‐bearing leucocytes to omalizumab in chronic spontaneous urticaria
BACKGROUND: The pathogenesis of chronic spontaneous urticaria (CSU) and the mechanism of action of omalizumab in CSU remain unclear. OBJECTIVE: In this study, we assessed the responsiveness and FcεRI expression of various subsets of leucocytes in patients with CSU treated with omalizumab. METHODS: I...
Autores principales: | Alizadeh Aghdam, Mehran, Knol, Edward F., van den Elzen, Mignon, den Hartog Jager, Constance, van Os‐Medendorp, Harmieke, Knulst, André C., Otten, Henny G., Röckmann, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065003/ https://www.ncbi.nlm.nih.gov/pubmed/31925825 http://dx.doi.org/10.1111/cea.13566 |
Ejemplares similares
-
Systemic and local evidence for complement involvement in chronic spontaneous urticaria
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2021) -
Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients
por: Dekkers, Coco, et al.
Publicado: (2021) -
Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria
por: van den Elzen, Mignon T., et al.
Publicado: (2017) -
Efficacy of Treatment of Non-hereditary Angioedema
por: van den Elzen, Mignon, et al.
Publicado: (2016) -
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
por: Metz, Martin, et al.
Publicado: (2017)